Viewing StudyNCT00444912



Ignite Creation Date: 2024-05-05 @ 5:24 PM
Last Modification Date: 2024-10-26 @ 9:31 AM
Study NCT ID: NCT00444912
Status: COMPLETED
Last Update Posted: 2014-03-13
First Post: 2007-03-07

Brief Title: The Effect of Rituximab on Mobilization With AMD3100 Plerixafor Plus G-CSF in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma NHL or Hodgkin Disease HD
Sponsor: Genzyme a Sanofi Company
Organization: Sanofi

Conditions & Keywords Data

Conditions:
Name
Hodgkin Disease
Non-Hodgkin Lymphoma
Keywords:
Name View
Hodgkin Disease View
AMD3100 View
stem cell mobilization View
autologous transplant View
Non-Hodgkin Lymphoma View